Orrick has been selected as the “Firm to Watch in Finance & Corporate” by LMG Life Sciences at its 2021 awards dinner. In addition, Orrick’s Stephen Thau was shortlisted as Venture Capital Attorney of the Year. LMG recognizes the individuals and companies behind the most innovative and challenging life sciences work of the past year.
Orrick acts for over 500 life science clients across all segments – biotech and pharma, digital health, research and laboratories, medical devices and diagnostics and tools. Over the past year, we’ve advised on more than 110 venture capital transactions for life sciences and healthtech startups, raising $3.2 billion, as well as counseled life sciences companies, Clover Health, SOC Telemed and Local Bounti on their SPAC transactions, and HCW Biologics on its IPO. Our litigation teams have also produced successful results for companies such as Gilead, Johnson & Johnson and others.